Allogene Therapeutics, Inc.
INDUCIBLE CHIMERIC CYTOKINE RECEPTORS

Last updated:

Abstract:

The present invention provides inducible chimeric cytokine receptors responsive to a ligand, e.g., a small molecule or protein, uses of such receptors for improving the functional activities of genetically modified immune cells, such as T cells, comprising the inducible chimeric cytokine receptors, and compositions comprising such cells.

Status:
Application
Type:

Utility

Filling date:

1 Mar 2019

Issue date:

26 Sep 2019